LadRx Corporation Navigation
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • NeuroDegenerative
    • Arimoclomol
  • Oncology
    • Aldoxorubicin
    • LADR™
  • Investors
    • Overview
    • Stock Information
    • Investor FAQs
    • Analyst Coverage
    • Annual Reports
    • SEC Filings
    • Corporate Governance
    • Presentations
    • Email Alerts
    • Information Request
    • Online Investor Kit
  • News & Events
    • Press Releases
    • Virtual Event
  • Contact
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • NeuroDegenerative
    • Arimoclomol
  • Oncology
    • Aldoxorubicin
    • LADR™
  • Investors
    • Overview
    • Stock Information
    • Investor FAQs
    • Analyst Coverage
    • Annual Reports
    • SEC Filings
    • Corporate Governance
    • Presentations
    • Email Alerts
    • Information Request
    • Online Investor Kit
  • News & Events
    • Press Releases
    • Virtual Event
  • Contact

Seeking better outcomes for patients

LadRx Corporation is a biopharmaceutical company focused on the discovery and development of new therapeutics to treat patients with high unmet medical needs

Learn More

Want to learn more about LadRx?

View our company presentation

Latest News

11/17/22 LadRx Corporation Issues Corporate Update for 3Q22
10/05/22 LadRx Corporation Announces OTCQB Ticker Change to LADX
09/23/22 CytRx Corporation Relaunches as LadRx Corporation
All News
 
  • About
  • NeuroDegenerative
  • Oncology
  • Investors
  • News & Events
  • Contact

© 2022 LadRx Corporation